B. Lynne Parshall - 15 Jul 2025 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Reporting relationship: Director
Issuer ticker: IONS
Reported as of: 15 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2025, 16:54:25 UTC
Prior SEC filing: 02 Jul 2025
Next SEC filing: 08 Aug 2025
Source filing: View source filing
Reporting owner signature: By: Patrick R. O'Neil, attorney-in-fact For: B. Lynne Parshall

Key filing fact

B. Lynne Parshall filed Form 4 for IONIS PHARMACEUTICALS INC (IONS) on 17 Jul 2025.

Key facts

This page summarizes B. Lynne Parshall's Form 4 filing for IONIS PHARMACEUTICALS INC (IONS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jul 2025, 16:54.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001073385 Primary reporting owner

PARSHALL B LYNNE

Relationship: Director
Address: 2855 GAZELLE COURT, CARLSBAD
Signature: By: Patrick R. O'Neil, attorney-in-fact For: B. Lynne Parshall
Signature date: 17 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IONS transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +4,079
Change %: +4.7%
Price: $0.000000
Shares after: 91,344
Date: 15 Jul 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IONS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -4,079
Change %: -44%
Price: $0.000000
Shares after: 5,220
Date: 15 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,079
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.

Footnote F2

Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.

Footnote F3

Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.